Clinical Research Service Provider Information Form

Similar documents
Survey of Research Nurse Training and Experience in a Paediatric Clinical Trial Setting

Information Brochure Professional Certificate in Pharmacovigilance

STANDARD OPERATING PROCEDURE

Trial Management: Trial Master Files and Investigator Site Files

53. MASTER OF SCIENCE PROGRAM IN GENERAL MEDICINE, UNDIVIDED TRAINING PROGRAM. 1. Name of the Master of Science program: general medicine

STANDARD OPERATING PROCEDURE

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Article 3(3) Certification

Unofficial copy not valid

PAED-Net the German Network

A National Model of Care for Paediatric Healthcare Services in Ireland Chapter 4: Vision for Paediatric Health Services

INDEX. L-SNT-1 - NURSING SCIENCE INFERMIERISTICA (CIVICO) Page 2. L-SNT-1- NURSING SCIENCE INFEMIERISTICA (POLICLINICO) Page 4

The CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI

Joint R&D Support Office SOP S-2011 UHL

FDA Medical Device Regulations vs. ISO 14155

Standard Operating Procedures

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

1. Introduction, purpose of this Standard Operating Procedure (SOP)

1. Introduction, purpose of this Standard Operating Procedure (SOP)

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

A Career in Big Pharma. Beatrice Tilt, GSK

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

-SQA- SCOTTISH QUALIFICATIONS AUTHORITY HIGHER NATIONAL UNIT SPECIFICATION GENERAL INFORMATION

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

2015 Physician Licensure Survey

CME Needs Assessment Summary

Clinical Trial Readiness Checklist October 2014

Pre-inspection documentation

CME Needs Assessment Summary 2015

MRCGP [INTERNATIONAL] BRUNEI INFORMATION BOOKLET

Auditing of Clinical Trials

Health Facility Guidelines

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

Retrospective Chart Review Studies

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Standard Operating Procedure (SOP) Research and Development Office

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

STANDARD OPERATING PROCEDURE SOP 325

Harrison Clinical Research. Monitoring of Clinical Trials - Quality Management from a CRO s Perspective

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

Question 1 a) What is the Annual net expenditure on the NHS from 1997/98 to 2007/08 in Scotland? b) Per head of population

(Prohibition or restriction of. PQ Alert - Education of. restriction of practice) minors (Prohibition or

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

CME Needs Assessment Summary

Overview ICH GCP E6(R2) Integrated Addendum

At PRI, we re all about focus.

Prerequisite Knowledge and Skills for Clinical Placements at SickKids

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Ref No 001/18. Incremental credit will be awarded in accordance with experience and qualifications.

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES

Prepared by the American College of Radiology Imaging Network Protocol Development and Regulatory Compliance Department

European network of paediatric research (Enpr-EMA)

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

Guidance notes for patient safety and pharmacovigilance in patient support programmes

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

Document Title: Investigator Site File. Document Number: 019

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

The GCP Perspective on Study Monitoring

Geisinger IRB Member Orientation Session 2. Debra L. Henninger, MHS RN CCRC Associate Director, Research Compliance

Alfred Health Pharmacy Internships 2019

Work plan for GCP Inspectors Working Group for 2018

Course Descriptions. CLSC 5227: Clinical Laboratory Methods [1-3]

...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS

Roll Out of the HIT Meaningful Use Standards and Certification Criteria

RADIATION SAFETY COMMITTEE

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

Chapter 48 - Bioresearch Monitoring

Introduction To Medpace & Clinical Research Overview

Risk Assessment and Monitoring

European network of paediatric research (EnprEMA)

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Standard Operating Procedure

SOP Title: Reporting Adverse Events and New Safety Information

Lessons from the EMA Patient Registries Initiative

Conducting Monitoring Visits for Investigator-Initiated Trials (IITs)

Clinical Research Professionals

ACCREDITATION OF PHASE I UNITS AND PROTECTION OF THE SUBJECTS PARTICIPATING IN CLINICAL TRIALS IN FRANCE

ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

NEW FRAMEWORK FOR SCIENTIFIC ADVICE & PROTOCOL ASSISTANCE

Investigator Site File Standard Operating Procedure (SOP)

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Standard Operating Procedure (SOP) Research and Development Office

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Use of disease registries for benefitrisk evaluation of medicines: A regulatory perspective. DIA Europe April Basel, Switzerland

Course program. Good Clinical Practice (GCP) course for surgeons

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO

Keele Clinical Trials Unit

IN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD

POLICIES AND PROCEDURES

NIHR Medicines for Children Research Network Response January 2010

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Transcription:

Clinical Research Service Provider Information Form General information Name of Organisation Vitalograph Ireland Ltd Contact information Head of Organisation Main contact Name: Frank Keane Address: Gort Road, Ennis, Co. Clare, Ireland Telephone: +353 65 6864100 Fax: +353 65 6829289 Email: frank.keane@vitalograph.ie Web Site: www.vitalograph.ie Brochure (please attach if available): Attached Name: Jonathan Pritchard Address: Gort Road, Ennis, Co. Clare, Ireland Telephone: +44 1280 827129 Fax: +44 1280 827110 Email: Jonathan.Pritchard@vitalograph.co.uk Does your organisation provide the following: Yes No Give details of experience Strategic Development Clinical Development plan Device Development plan (inc. design verification and validation) Diagnostic Development plan (inc. design verification and validation) Quality Management Vitalograph have a QMS with a full range of SOPs outlining how our equipment should be manufactured Page 1 of 5

and used within a clinical trials, Vitalograph s project management, device support and device manufacture services confirm with ISO13485:2003, ISO9001:2008, 21CFR 820 Risk Analysis Vitalograph perform a number of risk analysis steps during the development of a device or provision of services within a clinical trial. Risk is assessed that key points in a clinical study and strategies are implemented to mitigate or overcome risk where possible. These are outlined within the relevant SOPs Study Planning Vitalograph perform a comprehensive study plan during the provision of services within a clinical trial. The assigned project manager will create a project plan as well as delivering the services in timelines defined within the relevant SOPs Vendor Selection/Qualification When required Vitalograph have a in depth vendor selection and qualification strategy outlined within our SOPS Unitised costing model for services provided Can be provided on request Does your organisation have experience in Yes No Give details of experience the following study types: Observational Studies Health Surveys Clinical Trials on Investigational Medicinal Products (IMPs) Vitalograph provide equipment and support services to respiratory clinical trials in order to meet our Sponsor s needs. We have worked on over 40 clinical trials from phase I to IV in a number of countries around the world. Clinical Investigations on Medical Devices Clinical Studies on Diagnostics Biobanking Studies Vitalograph were involved in the UK Biobank study Page 2 of 5

Does your organisation provide the following: Yes No Give details of experience Project Provide consultation Management throughout all stages of the study process Identification of investigators/centres Protocol/CIP design: 1. Systematic review and meta-analysis 2. Methodology 3. Biostatistical design 4. Protocol/CIP writing Investigator Brochure Preparation Informed Consent Clinical trial services Regulatory Affairs/Ethics submissions Access to laboratory and preparation Project manager Medical monitoring Clinical research monitoring Qualified Person (QP) IMP batch release Qualified Person Pharmacovigilance (QPPV) Clinical Trial Applications phase I to IV for IMP Clinical Investigation Applications for medical devices Notification for Diagnostics Ethics Committee submission Central laboratory Core laboratory Page 3 of 5

clinical services Radiology ECG, BP monitoring etc. Other Respiratory data Over-reading services Medical writing Annual safety reports and reporting Clinical study reports Periodic Safety Update Report (PSUR) Biometrics Statistics Data management Provision of centralised data capture for provided spirometry/e-diary services allowing with study specific reporting services. ecrf/ CRFdesign Submissions Competent Authorities Notified Bodies FDA Other Reimbursement Pharmacoeconomics Health Technology Regulatory experience in therapeutic areas Assessments Cardiology Oncology Endocrinology Immunology Orthopaedics Neurology Psychiatry Infectious Diseases Dermatology Internal Medicine Paediatrics Interventional Radiology Page 4 of 5

Sensor Technologies Respiratory Abbreviations: IMP Investigational Medicinal Product CIP Clinical Investigation Plan BP Blood Pressure ECG Electrocardiogram ecrf Electronic Case Report Form CRF Case Report Form FDA Food and Drug Administration Page 5 of 5